Argus lowered the firm’s price target on Illumina (ILMN) to $100 from $170 and keeps a Buy rating on the shares. The stock has fallen ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Illumina (ILMN – Research Report) and Arcellx ...
4don MSN
Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback